WO2023026194 - SEQUENCES AND PROMOTERS FOR USE IN PLANT CELLS AND METHODS OF MAKING AND USING SUCH SEQUENCES
National phase entry:
Publication Number
WO/2023/026194
Publication Date
02.03.2023
International Application No.
PCT/IB2022/057897
International Filing Date
23.08.2022
Title **
[English]
SEQUENCES AND PROMOTERS FOR USE IN PLANT CELLS AND METHODS OF MAKING AND USING SUCH SEQUENCES
[French]
SÉQUENCES ET PROMOTEURS DESTINÉS À ÊTRE UTILISÉS DANS DES CELLULES VÉGÉTALES ET PROCÉDÉS DE FABRICATION ET D'UTILISATION DE CES SÉQUENCES
Applicants **
FUTURAGENE ISRAEL LTD.
2 Pekeris Street
Park Tamar
7670202 Rehovot, IL
Inventors
AVISAR, Dror
01 HaEm Street
5225201 Ramat Gan, IL
AZULAY, Shelly
11 Sokolov Street
7409329 Ness Ziona, IL
Priority Data
63/236,474
24.08.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1403 | |
| EPO | Filing, Examination | 9225 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3480 |
Total: 15274 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure is directed to a novel sequence constructed from viral elements for use as a transgenic promoter; for example, in transgenic plants. More specifically, the present disclosure is directed to a chimeric transgenic promoter sequence comprising a portion derived from the Figwort Mosaic Virus (FMV / FiMV) genome and a portion derived from the Cassava Vein Mosaic Virus (CsVMV) genome. The present disclosure provides methods and compositions for the making and using such a transgenic promoter.[French]
La présente invention concerne une nouvelle séquence construite à partir d'éléments viraux pour une utilisation en tant que promoteur transgénique ; par exemple, dans des plantes transgéniques. Plus particulièrement, la présente invention concerne une séquence de promoteur transgénique chimérique comprenant une partie dérivée du génome du virus de la mosaïque du figuier (FMV / FiMV) et une partie dérivée du génome du virus de la mosaïque de la veine du manioc (CsVMV). La présente invention concerne des procédés et des compositions pour la fabrication et l'utilisation d'un tel promoteur transgénique.